School of Medicine

Vitamin D supplements may ease joint and muscle pain in breast cancer patients taking the drug Arimidex.

Faculty who conduct research in diabetes and endocrinology may apply for grant funding from the Diabetes Research and Training Center in the School of Medicine.

Kelle H. Moley, M.D., has been named vice chair for basic science research and director of the Division of Basic Science Research in the Department of Obstetrics and Gynecology.

Photo by Ray MarklinStudents Chris Sumey, Michelle Moniz and Andy Zimolzak rehearse Guys and Dolls, which will be staged April 7, 8 & 15.

In the last 30 years, the number of overweight children has doubled in the United States, and overweight children are at increased risk for the problem. More medical news

Kelle H. Moley, M.D., an associate professor of obstetrics and gynecology, has been named vice chair for basic science research and director of the Division of Basic Science Research in the Department of Obstetrics and Gynecology.

Researchers at the School of Medicine have added a gene in the bacterium Salmonella to the short list of genes regulated by a new mechanism known as the riboswitch.

Neurons (shown here in green) fire more frequently in mice lacking Kv4.2 potassium channels.Studying mice, pain researchers at the School of Medicine have identified key components in the pain cascade that may provide targets for more effective analgesic drugs with potentially fewer side effects. Scientists have identified a potassium channel that plays a crucial role in what scientists call pain plasticity, the ability of molecules in the spinal cord to amplify or diminish the response to a painful stimulus.

Restricting calories may mean living longer.Can eating a low-calorie yet nutritionally balanced diet extend human life as it does in rodents? Preliminary research suggests it might, so researchers at Washington University School of Medicine in St. Louis are launching a long-term study to find out. More…

Islets isolated from a rat pancreasDiabetes researchers hoping to enlist the help of a protein targeted by cancer therapies have gained an important new insight into how the protein, known as mTOR, works in the pancreas. Ironically, diabetes researchers are hoping to promote the capability of mTOR that oncologists want to shut down: its ability to cause cells to reproduce by dividing into copies of themselves. That capacity can be deadly in tumors, but diabetes researchers want to use mTOR’s ability to make cells divide to maintain enough insulin-making beta cells in the pancreas to prevent diabetes. More…